Dual GLP-1/GIP agonist (Mounjaro/Zepbound). More effective than semaglutide for weight and glucose. Start 2.5mg, titrate every 4 weeks: 5mg > 7.5mg > 10mg > 12.5-15mg max.
GLP-1 agonist (Ozempic/Wegovy). Slows gastric emptying, increases satiety, improves insulin sensitivity. Start 0.25mg x4wks > 0.5mg x4wks > 1.0mg > 1.7-2.0mg max for higher BMI.
Triple-agonist (GLP-1/GIP/glucagon). Combines appetite suppression with increased energy expenditure. Titrate: 2.5mg > 5mg > 7.5mg > 10mg > 12-12.5mg over 12-24 weeks. Still investigational.
A modified GHRH analog providing pulsatile GH release. Best combined with Ipamorelin. Requires strict fasting: 90 min before and 30-60 min after injection.
Long-acting GHRH analog with Drug Affinity Complex (~8 day half-life). No fasting needed. Less ideal for acute timing vs no-DAC version.
The cleanest GHRP - minimal GH side effects, doesn't increase cortisol or prolactin. Requires strict fasting pre- and post-injection. Best stacked rather than solo.
FDA-approved GHRH analog (Egrifta). Requires fasting 30-60 min pre- and post-injection. Primarily studied for visceral fat reduction and lipid profile modulation.
Long-acting IGF-1 variant. IM injection preferred at or near target muscle. May cause hypoglycemia - post-admin carb intake recommended. Cycle 2 weeks on / 1 week off.
Body Protection Compound-157, a gastric pentadecapeptide. Inject SubQ as close to injury as possible. Oral version available for gut repair (IBD, IBS, ulceration). 4-6 week cycles typical.
Synthetic Thymosin Beta-4 fragment. Systemic effects (circulatory, anti-inflammatory) - inject anywhere. 4-6 week loading phase, then 4-6 week maintenance. Avoid injecting into joint capsules directly.
The full 43-amino acid peptide from which TB-500 is derived. Promotes wound healing and tissue repair.
Copper tripeptide studied for skin, healing, and post-procedural recovery. SubQ may cause minor bluish discoloration from copper content. Highly safe for long-term use.
Approved in 35+ countries (Zadaxin) for hepatitis and cancer adjuvant. 4-6 week cycles typical. Acute infection: 1.5mg daily for 7-10 days. Store properly (cold-chain preferred).
The body's master antioxidant, a tripeptide (glutamate, cysteine, glycine) critical for detoxification, immune function, and cellular protection. Injectable or liposomal forms bypass poor oral absorption.
Nicotinamide adenine dinucleotide, a critical coenzyme for cellular energy production, DNA repair, and sirtuin activation. Injectable forms provide superior bioavailability compared to oral precursors like NMN or NR.
A tetrapeptide studied for telomerase activation. Used 1-2x annually during anti-aging 'resets' (fall or spring cycles). No known desensitization or GH axis suppression.
Russian-approved nootropic (ACTH 4-10 analog). Do not lie down 10-15 min post-application. Safe for long-term use, some cycle to maintain sensitivity.
Russian-approved anxiolytic peptide. Rapid onset (15-30 min). Very mild with minimal tolerance build-up. May increase sociability and reduce obsessive thought cycles.
An enhanced variant of Semax with an adamantane group attached, providing improved blood-brain barrier penetration and longer-lasting effects. More potent than standard Semax with enhanced neuroprotective and nootropic properties.
An angiotensin IV analog with powerful nootropic effects. Million times more potent than BDNF for synapse formation.
A peptide mixture derived from pig brain with neurotrophic properties. Used clinically for stroke and dementia.
Thymic bioregulator used every 3-6 months. Pain-free and well-tolerated. No known GH axis effects. Longevity protocol: stack with Epithalon 2x/year for thymic restoration.
A pre-mixed skin rejuvenation blend combining GHK-Cu (50mg), BPC-157 (10mg), and TB-4 (10mg). GHK-Cu drives collagen synthesis and gene regulation, BPC-157 builds blood vessel networks, and TB-4 organizes cell migration for anti-scarring. Best for firmness, texture, fine lines, and general skin quality.
GLOW blend plus KPV anti-inflammatory peptide. Contains GHK-Cu (50mg), BPC-157 (10mg), TB-4 (10mg), and KPV (10mg). KPV blocks NF-kB inflammatory signaling and shifts immune cells to repair mode. Best for reactive skin, rosacea, post-procedure recovery, or when inflammation limits GLOW results.
The most widely used peptide protocol for injury recovery combining BPC-157 and TB-500. BPC-157 restores blood flow via VEGF upregulation and builds vascular networks. TB-500 mobilizes repair cells through actin polymerization and shifts immune cells to repair mode. Named for exceptional tissue repair capabilities.
A dual glucagon/GLP-1 receptor agonist in development for obesity and NASH. Shows promising metabolic benefits.
A long-acting amylin analogue that reduces appetite and slows gastric emptying. Often combined with semaglutide.
A daily GLP-1 agonist marketed as Victoza/Saxenda. First GLP-1 approved for weight management.
A modified fragment of HGH (amino acids 176-191). Purely lipolytic - does not increase GH or IGF-1. Best used with exercise in a low-insulin environment.
A mitochondrial-derived peptide that enhances AMPK activity and glucose utilization. Improves insulin sensitivity. No GH-related desensitization risk.
Also known as IBI362, a dual GLP-1/glucagon receptor agonist in development showing strong weight loss results.
A mitochondrial-derived peptide with neuroprotective and metabolic benefits. Shows promise for aging and metabolic disease.
Also known as Exendin-4, the first GLP-1 receptor agonist. Derived from Gila monster venom.
FDA-approved (Vyleesi) melanocortin receptor agonist. Works via MC4R in brain - neurologically mediated, not hormonal. Studied for arousal and social interaction pathways.
Potent GH secretagogue binding ghrelin receptors. Stronger GH pulse than ipamorelin but more side effects. Best paired with a GHRH like CJC-1295.
Growth Hormone Releasing Peptide-6, known for strong GH release and significant appetite stimulation.
One of the most potent GH secretagogues available. Strong GH release but causes desensitization.
GHRH fragment 1-29, one of the first GHRH analogs. Promotes natural GH production pattern.
An oral non-peptide GH secretagogue (not technically a peptide). Provides sustained 24-hour GH/IGF-1 elevation. Extensively studied but not FDA approved.
A myostatin inhibitor that blocks the muscle-limiting protein myostatin. Promotes significant muscle growth.
A truncated form of IGF-1 that is 10x more potent. Very short half-life (~20-30 min) - inject at or near target tissue immediately post-workout.
Pegylated Mechano Growth Factor with extended half-life. Promotes muscle satellite cell activation.
The lipolytic fragment of human growth hormone. Specifically targets fat burning without other GH effects.
Anti-inflammatory tripeptide derived from alpha-MSH. Shows promise for gut health and inflammation.
A neuropeptide with wide-ranging effects on immune function, inflammation, and circadian rhythm.
A human antimicrobial peptide (cathelicidin) with broad-spectrum antimicrobial and immunomodulatory effects.
A neuropeptide mixture with brain-protective properties. Used in Russia for various neurological conditions.
A cerebrolysin-derived peptide that promotes neurogenesis and enhances BDNF activity.
A peptide-derived nootropic (dipeptide analog) with anxiolytic and cognitive enhancing effects. 1000x more potent than piracetam.
Commonly studied for sleep onset, delta wave enhancement, and circadian rhythm balance. No known tolerance build-up. Often associated with vivid dreams and early morning alertness.
A synthetic alpha-MSH analog that increases melanin production. FDA approved for certain conditions.
Alpha-MSH analog. Loading: 250mcg increasing to 1mg over 7-14 days, then maintenance 1-2x/week. Titrate 100mcg increments every 2-3 days to minimize side effects.
An anti-wrinkle octapeptide that inhibits muscle contraction, similar to botox but topical.
An anti-wrinkle peptide that inhibits SNARE complex formation, reducing muscle contraction and wrinkles.
A palmitoyl pentapeptide combination that stimulates collagen and reduces wrinkle depth.
A senolytic peptide that selectively induces apoptosis in senescent cells. Cutting-edge anti-aging research.
A pineal gland bioregulator that supports melatonin production and circadian rhythm.
A synthetic ERRα/γ agonist that mimics the metabolic effects of exercise. Known as an 'exercise mimetic' that activates pathways normally triggered by physical activity.
Growth Differentiation Factor 15, a stress-response hormone that suppresses appetite through brainstem signaling.
Islet amyloid polypeptide, co-secreted with insulin. Slows gastric emptying and promotes satiety.
A synthetic amylin analogue marketed as Symlin. Approved for diabetes, helps with appetite and blood sugar.
A dual GLP-1/glucagon receptor agonist naturally produced in the gut. Predecessor to modern dual-agonists.
A once-daily GLP-1 receptor agonist marketed as Adlyxin. Often combined with basal insulin.
A shorter-acting variant of follistatin that inhibits myostatin with potentially different tissue targeting.
A soluble activin receptor type IIB fusion protein. Traps myostatin and related proteins.
A splice variant of IGF-1 that activates muscle satellite cells. Short-acting, requires local injection.
An oral ghrelin receptor agonist developed for cancer cachexia. Increases appetite and lean body mass.
An erythropoietin-derived tissue protective peptide that reduces inflammation and promotes repair without affecting red blood cells.
A tight junction regulator that reduces intestinal permeability. Developed for celiac disease.
A short dipeptide bioregulator that supports immune function and thymus health.
A cartilage bioregulator peptide that supports joint health and cartilage regeneration.
A pancreatic bioregulator that supports pancreas function and metabolic health.
An NCAM-derived peptide that promotes synaptic plasticity and has shown benefits in cognitive research.
The 'bonding hormone' that enhances social behavior, trust, and has anxiolytic properties.
Antidiuretic hormone with cognitive effects. Enhances memory and attention.
A short neuropeptide bioregulator that supports brain function and normalizes sleep patterns.
A peptide that stimulates GnRH release, regulating testosterone and LH. Research for reproductive health.
Synthetic gonadotropin-releasing hormone that stimulates LH and FSH. Used for fertility and TRT support.
A potent GnRH agonist that initially stimulates then suppresses gonadotropins. Used medically for various conditions.
A liver and immune bioregulator peptide that supports hepatic function and DNA repair.
A vascular bioregulator that supports blood vessel health and endothelial function.
An immune bioregulator that supports overall immune function and resistance to infection.
A liver bioregulator peptide that supports hepatic function and metabolic processes.
A testicular bioregulator that supports reproductive and hormonal function in males.
A respiratory bioregulator that supports lung and bronchial health.
A respiratory bioregulator peptide that supports lung tissue and respiratory health.
A retinal bioregulator that supports eye health and visual function.
A thymus bioregulator that supports immune function and thymic health.
A dipeptide immune stimulant that supports thymus function and immune response.
A proapoptotic peptide that targets blood vessels supplying fat tissue, causing fat cell death. Experimental.
Synthetic version of the native hormone that raises blood sugar and promotes fat breakdown. Used in dual-agonist research.
An FDA-approved oral GH secretagogue used for diagnosing adult GH deficiency.
